The December 2019 outbreak of a novel respiratory virus, SARS-CoV-2, has become an
ongoing global pandemic due in part to the challenge of identifying symptomatic, asymptomatic, …

We identified an emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples …

Background & Aims Hepatitis B virus (HBV) RNA in serum has recently been linked to
efficacy and prognosis of chronic hepatitis B (CHB) treatment. This study explored the nature, …

Virus-like particle (VLP) and live virus assays were used to investigate neutralizing immunity
against Delta and Omicron SARS-CoV-2 variants in 259 samples from 128 vaccinated …

SARS-CoV-2 infection is characterized by peak viral load in the upper airway prior to or at
the time of symptom onset, an unusual feature that has enabled widespread transmission of …

Direct, amplification-free detection of RNA has the potential to transform molecular diagnostics
by enabling simple on-site analysis of human or environmental samples. CRISPR–Cas …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) readily infects a variety
of cell types impacting the function of vital organ systems, with particularly severe impact on …

SARS-CoV-2 Delta and Omicron are globally relevant variants of concern. Although individuals
infected with Delta are at risk of developing severe lung disease, infection with Omicron …

We identified a novel SARS-CoV-2 variant by viral whole-genome sequencing of 2,172
nasal/nasopharyngeal swab samples from 44 counties in California. Named B. 1.427/B. 1.429 to …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant contains
extensive sequence changes relative to the earlier-arising B.1, B.1.1, and Delta SARS-…